Drug
Cytotec®
Cytotec® is a pharmaceutical drug with 6 clinical trials. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
2
33%
Ph phase_4
2
33%
Ph phase_1
1
17%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(2)
Terminated(1)
Other(3)
Detailed Status
unknown3
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 42 (40.0%)
N/A2 (40.0%)
Trials by Status
completed233%
unknown350%
terminated117%
Recent Activity
0 active trials
Showing 5 of 6
terminated
Labor Protocol Study
NCT04004845
completedphase_1
Comparative Bioavailability Study of Two Misoprostol Formulations
NCT02516631
unknownnot_applicable
A Prospective Study of Misoprostol Administration in Asymptomatic Patients With Pregnancies of Unknown Location
NCT02581761
completedphase_4
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
NCT00393198
unknownnot_applicable
Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of Pregnancy
NCT02013960
Clinical Trials (6)
Showing 6 of 6 trials
NCT04004845
Labor Protocol Study
NCT02516631Phase 1
Comparative Bioavailability Study of Two Misoprostol Formulations
NCT02581761Not Applicable
A Prospective Study of Misoprostol Administration in Asymptomatic Patients With Pregnancies of Unknown Location
NCT00393198Phase 4
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
NCT02013960Not Applicable
Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of Pregnancy
NCT00256009Phase 4
Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6